ManpowerGroup filed an 8-K on October 28, 2026, announcing the election of Lidia Fonseca, former Executive Vice President and Chief Digital and Technology Officer at Pfizer, to its Board of Directors, effective November 1, 2026.

Key Highlights

  • New director elected: Lidia Fonseca joins ManpowerGroup's Board of Directors, effective November 1, 2026.
  • Prior role: Fonseca served as Chief Digital and Technology Officer and Executive Vice President of Pfizer from January 2019 to April 2026.
  • Current advisory role: Fonseca currently serves as Senior Advisor to Pfizer's Chief Executive Officer.
  • Other board service: Fonseca currently serves on the Board of Directors of Medtronic plc.
  • Earlier career: Fonseca previously served as Senior Vice President and Chief Information Officer at Quest Diagnostics and at LabCorp, and held executive roles at Philips Healthcare.
  • Education: Fonseca holds a bachelor's degree from the University of California, Berkeley, and an MBA and a Master of Business Informatics from Rotterdam School of Management at Erasmus University.

ManpowerGroup Adds Pfizer Technology Leader Lidia Fonseca to Its Board

According to the filing, ManpowerGroup (NYSE:MAN) announced on October 28, 2026, that Lidia Fonseca has been elected to its Board of Directors, with her appointment taking effect November 1, 2026. Fonseca's most recent principal role was Executive Vice President and Chief Digital and Technology Officer at Pfizer, a position she held from January 2019 to April 2026. In that capacity, the filing states she led "the company's enterprise AI, digital, data and technology strategy, as well as Learning and Development, and Business Process Excellence."

The filing further states that Fonseca "built Pfizer's enterprise AI program from inception, and scaled it across the enterprise, contributing to significant growth and cost savings." As of the announcement date, she continues in an advisory capacity as Senior Advisor to Pfizer's Chief Executive Officer and also sits on the Board of Directors of Medtronic plc, according to the disclosure.

The filing notes that prior to her time at Pfizer, Fonseca spent approximately a decade in diagnostics, serving as Senior Vice President and Chief Information Officer at Quest Diagnostics and, before that, at LabCorp. She began her career in operations and executive leadership roles at Philips Healthcare. ManpowerGroup Chair and CEO Jonas Prising is quoted in the filing as saying Fonseca "brings a rare combination of technology leadership, business transformation experience and a clear understanding of how AI can create value at scale."

What Was Disclosed

ManpowerGroup disclosed the election of Lidia Fonseca to its Board of Directors, effective November 1, 2026. The filing details her professional background at Pfizer, Quest Diagnostics, LabCorp, and Philips Healthcare, as well as her current board service at Medtronic plc.